83915-83-7
83915-83-7
Chemical Structure
Lisinopril dihydrate
Synonym(s): MK-521 dihydrate
- CAS No.: 83915-83-7
- Formula:C21H35N3O7
- Molecular Weight:441.52
IUPAC Name: ((S)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline dihydrate
InChIKey: CZRQXSDBMCMPNJ-ZUIPZQNBSA-N
SMILES: O=C(O)[C@H]1N(C([C@H](CCCCN)N[C@H](C(O)=O)CCC2=CC=CC=C2)=O)CCC1.O.O
Biological Activity: Lisinopri dihydrate (MK-521 dihydrate) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lisinopril dihydrate | 99.96% | Lisinopri dihydrate (MK-521 dihydrate) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lisinopril dihydrate (Standard) | ≥98% | Lisinopril (dihydrate) (Standard) is the analytical standard of Lisinopril (dihydrate). This product is intended for research and analytical applications. Lisinopri dihydrate (MK-521 dihydrate) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.98
HY-18206Lisinopril -
Similarity Score 0.81
HY-B0231Enalaprilat dihydrate -
Similarity Score 0.80
HY-B0231AEnalaprilat -
Similarity Score 0.72
HY-B0331Enalapril -
Similarity Score 0.70
HY-18206SLisinopril-d5 -
Similarity Score 0.69
HY-B0331AREnalapril maleate (Standard) -
Similarity Score 0.68
HY-B0331S1Enalapril-d3 -
Similarity Score 0.67
HY-A0116ATrandolaprilate hydrate -
Similarity Score 0.67
HY-B0331BEnalapril sodium -
Explore the MedChemAI to find more analogs
